Supplementary Figure from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Autor: Rui-Hua Xu, Yu-Hong Li, Feng-Hua Wang, Dong-Sheng Zhang, Hui-Yan Luo, Shuang-Zhen Chen, Si-Mei Shi, Ying Guo, Hong Qiu, Zhi-Qiang Wang, Zong-Jiong Mai, Ying Jin, Xiang-Yuan Wu, Zeng-Qing Guo, Qing-Feng Zou, Ying Yuan, Jie-Er Ying, Fu-Xiang Zhou, Zhi-Xiang Zhuang, Yi-Chen Yao, Zhi-Gang Ma, Xiao-Hua Hu, Wei Wang, Yan Zhang, Wei-Jia Fang, Xiang-Lin Yuan, Yan-Qiao Zhang, Jian Xiao, Ming-Ming He, Feng Wang
Rok vydání: 2023
DOI: 10.1158/1078-0432.22488381.v1
Popis: Supplementary Figure from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Databáze: OpenAIRE